John Lucey to Transition from CEO of Shields Health Solutions after Decade-Plus of Success
John Lucey, Co-Founder & Advisor STOUGHTON, Mass. — Shields Health Solutions, the premier specialty pharmacy accelerator in the country, announced today that Co-founder and Chief Executive Officer John Lucey…
RA Outcomes 2022
RA is an autoimmune and inflammatory disease where the immune system attacks healthy cells, causing inflammation and painful swelling in the affected parts of the body.
MS Outcomes 2022
MS is a chronic, autoimmune disease of the central nervous system, affecting the communication between the brain and other parts of the body
Hep-C Outcomes 2022
Hepatitis C is a liver infection caused by the hepatitis C virus (HCV) and is spread through contact with the blood of an infected person.
The Challenge of Financial Toxicity in Cancer Care: a Focus on Oral Oncology
HIV Viral Load Suppression in Patients Utilizing an Integrated Health System Specialty Pharmacy Compared to a Non Integrated Specialty Pharmacy Model
This poster highlights that among patients evaluated at UMass Memorial HIV Clinic, those filling ARV medications at the HSSP exhibited higher rates of viral suppression in comparison to patients utilizing…
Pharmacy Liaison-Managed Diabetes Care Model Yields Positive Outcomes
This article was originally published by Specialty Pharmacy Continuum GRAPEVINE, Texas—Integrating pharmacy technicians into endocrinology clinics to help manage administrative burdens such as prior authorizations and medication refills for patients…
Walgreens Boots Alliance ‘Specialty Pharmacy Accelerator’ Says It Helps Lower Out-of-Pocket Costs, Improve Outcomes for People with MS
This article was published in Managed Healthcare Executive on Sep 20, 2023. Learn how Shields Health Solutions is improving outcomes for people living with complex, chronic conditions, such as Multiple…